Previous page Next page

iEmoji Feeds @Paola Morejón Barragán (paomorejon) 2

12.

paomorejon
Hydroxychloroquine in patients with #COVIDー19: an open-label RCT

150

NOT increase of negative conversion rate… twitter.com/i/web/status/1…
Retweet of status by @paomorejon
15 Apr 20 copy & paste +upvote -downvote 🚨Hydroxychloroquine in patients with #COVIDー19: an open-label RCT 👥150 NOT increase of negative conversion rate… https://t.co/ryw0sSB0bm

13.

paomorejon
Statement
The AHA, the HFSA and the ACC recommend continuation of angiotensin converting enzyme inhibitors (ACE-i)… twitter.com/i/web/status/1…
17 Mar 20 copy & paste +upvote -downvote 📌Statement The AHA, the HFSA and the ACC recommend continuation of angiotensin converting enzyme inhibitors (ACE-i)… https://t.co/LtV42htm9G
14.
paomorejon
EHRA international consensus document on how to prevent, diagnose, and treat cardiac implantable electronic device… twitter.com/i/web/status/1…
Retweet of status by @paomorejon
28 Feb 20 copy & paste +upvote -downvote 📌EHRA international consensus document on how to prevent, diagnose, and treat cardiac implantable electronic device… https://t.co/JXWfy6E2uf
15.
paomorejon
13728 ARIC cohort
22y
2,696 (20%) developed incident HF, 729 subsequent VTE events
HF (HFpEF/HFrEF)was associ… twitter.com/i/web/status/1…
Retweet of status by @ValleAlfonso
13 Jan 20 copy & paste +upvote -downvote 👥13728 ARIC cohort ⏰22y 🎯 2,696 (20%) developed incident HF, 729 subsequent VTE events 💡 HF (HFpEF/HFrEF)was associ… https://t.co/pqu2PKz3GW
16.
paomorejon
Dapagliflozin & Prevention of Adverse outcomes in DAPA-HF
neprilysinBblockerMRASGLT2i
using together is emi… twitter.com/i/web/status/1…
Retweet of status by @ValleAlfonso
03 Jan 20 copy & paste +upvote -downvote Dapagliflozin & Prevention of Adverse outcomes in DAPA-HF⤵️ ↪️neprilysin➕Bblocker➕MRA➕SGLT2i 📍using together is emi… https://t.co/XF0H9kaMRe
17.
paomorejon
Metformin on myocardial efficiency in insulin-resistant chronic #HeartFailure patients without #diabetes
Addition… twitter.com/i/web/status/1…
22 Dec 19 copy & paste +upvote -downvote 📌Metformin on myocardial efficiency in insulin-resistant chronic #HeartFailure patients without #diabetes Addition… https://t.co/Qo3u32J9xa
18.
paomorejon
At the current price of $73 000 per year, adding canakinumab to standard therapy for secondary prevention of cardi… twitter.com/i/web/status/1…
Retweet of status by @ValleAlfonso
17 Jan 19 copy & paste +upvote -downvote 🗣At the current price of $73 000 per year, adding canakinumab to standard therapy for secondary prevention of cardi… https://t.co/VQApfuPFYJ
19.
30 Aug 18 copy & paste +upvote -downvote I love to read it. 😍 #HeartFailure #InsuficienciaCardiaca #CardioEd https://t.co/KpKaQwf3GH
20.
paomorejon
Patients with CAD & LVEF>35%, Sudden/arrhythmic death occurred most often at home without antecedent clinical wo… twitter.com/i/web/status/1…
Retweet of status by @ValleAlfonso
19 Jul 18 copy & paste +upvote -downvote Patients with CAD & LVEF>35%, 1️⃣Sudden/arrhythmic death occurred most often at home without antecedent clinical wo… https://t.co/rb0fUJRsuH

...but wait! There's more!

12.

fakhright
fakhright @fakhright
astaghfirullah peng.krim guaaaaaaaa..............a *salto sambil solat*
14 Jan 13 copy & paste +upvote -downvote astaghfirullah peng.krim guaaaaaaaa..............a *salto sambil solat* 🙈🙈🙊
Previous page Next page
https://www.iemoji.com/feed/paomorejon
Back to top